Insulin therapy in children and adolescents with type 1 diabetes. (Q51313300)

3 April 2018

title

Insulin therapy in children and adolescents with type 1 diabetes. (English)

1 reference

3 April 2018

0 references

1 reference

1 reference

Faisal S Malik

1

1 reference

3 April 2018

Craig E Taplin

series ordinal

2

1 reference

3 April 2018

publication date

1 April 2014

1 reference

3 April 2018

published in

Pediatric Drugs

1 reference

3 April 2018

volume

16

1 reference

3 April 2018

issue

2

1 reference

3 April 2018

page(s)

141-150

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s40272-014-0064-6

exact match

0 references

cites work

Definition, epidemiology and classification of diabetes in children and adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Clinical pharmacology of human insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin treatment in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulins: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin analogues and their potential in the management of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

An update on the long-acting insulin analogue glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Diabetic ketoacidosis in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Assessment and monitoring of glycemic control in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the SEARCH for Diabetes in Youth study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Predictors of control of diabetes: monitoring may be the key.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

The use of insulin pump therapy in the pediatric age group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

The barrier of hypoglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Decreased epinephrine responses to hypoglycemia during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Exercise in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Physical activity, sport, and pediatric diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin resistance during puberty: results from clamp studies in 357 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Longitudinal study on pubertal insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Insulin degludec and insulin degludec/insulin aspart: a review of their use in the management of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Closed-loop insulin delivery in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Feasibility of automating insulin delivery for the treatment of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Standards of medical care in diabetes--2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Assessment and management of hypoglycemia in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

The Dawn Phenomenon Is Related To Overnight Growth Hormone Release In Adolescent Diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40272-014-0064-6

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes

21 January 2018

1 reference

12 December 2020

An ambulatory stabilisation program for children with newly diagnosed type 1 diabetes

1 reference

12 December 2020

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

1 reference

12 December 2020

1 reference

12 December 2020

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

1 reference

12 December 2020

The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study

1 reference

12 December 2020

The rising incidence of childhood type 1 diabetes in New South Wales, 1990-2002.

1 reference

12 December 2020

Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial

1 reference

12 December 2020

Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin

1 reference

12 December 2020

[Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin

1 reference

12 December 2020

Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study

1 reference

12 December 2020

Pancreatic Extracts in the Treatment of Diabetes Mellitus

1 reference

12 December 2020

Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes

1 reference

12 December 2020

Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes,

1 reference

12 December 2020

1 reference

12 December 2020

Continuous glucose monitoring systems for type 1 diabetes mellitus

1 reference

12 December 2020

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

1 reference

12 December 2020

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

1 reference

12 December 2020

Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens

1 reference

12 December 2020

10.1007/S40272-014-0064-6

Identifiers

DOI

1 reference

3 April 2018

release_r7dogfhbfjbmxlpwoen4nwsgoa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r7dogfhbfjbmxlpwoen4nwsgoa

24 November 2022

mapped directly with Wikidata item

PubMed ID

24458650

1 reference

3 April 2018